Dr. Tridandapani is a member of the Leukemia Research Program at the OSUCC and the Division of Hematology. Her research focuses on the molecular mechanisms of innate immune responses to bacterial pathogens and immunoglobulin G complexes. In particular, she is interested in macrophage biology related to cancer immunotherapy. Her work is funded by the National Cancer Institute and the National Institute of Allergy and infectious Diseases. Dr. Tridandapani is passionate about mentorship. She has served for 10 years as the director for Research in the Center for FAME providing mentorship and guidance to junior faculty toward their career development.

Dr. Rojas’s early work included pioneering studies on bone-marrow derived mesenchymal stem cells as potential therapies, and more recently, he has focused on mesenchymal cell aging and senescence with the innovative incorporation of ex-vivo lung perfusion models to study the impact of therapeutic interventions on lung pathology.

View academic profile

Congratulations to Jay Zweier in Cardiology: R01CA270608 “Electronic cigarette derived free radicals, oxidative stress and inflammation in lung cancer development”

Congratulations to Orlando Simonetti, PhD, Professor of Cardiovascular Medicine, for his new R01 titled: "Development and validation of cardiovascular MRI techniques on a low-field, ultra-wide bore system to assess patients with severe obesity."

Congratulations to John Christman, Professor in the Division of Pulmonary and Critical Care, for the renewal of his RO1 titled: "Regulation of the macrophage inflammatory phenotype in ARDS."

Dr. Christman has been an NIH funded investigator for more than 20 years without interruption.